期刊文献+

急性心肌梗死患者ApoB/ApoAⅠ比值与颈动脉斑块类型的关系 被引量:3

Relationship Between ApoB / ApoAⅠ Ratio and Carotid Plaque Type in Patients with Acute Myocardial Infarction
下载PDF
导出
摘要 目的探讨急性心肌梗死患者血清载脂蛋白B(Apo B)、载脂蛋白AⅠ(Apo AⅠ)水平及其比值与颈动脉粥样硬化斑块类型的关系。方法对65例急性心肌梗死患者(病变组)及36例冠状动脉正常者(对照组)行颈动脉超声检查及Apo B、Apo AⅠ水平测定,计算Apo B/Apo AⅠ比值。根据超声检查结果将所有患者颈动脉斑块分为软斑块、纤维斑块、钙化斑块,对各种数据进行统计学分析。结果病变组软斑块的检出率明显高于对照组(P<0.001),病变组载脂蛋白B水平、Apo B/Apo AⅠ比值均高于对照组(P<0.05);病变组中软斑块者载脂蛋白B水平、Apo B/Apo AⅠ比值较纤维斑块者和钙化斑块者高(P<0.05);对照组中软斑块者载脂蛋白B水平、Apo B/Apo AⅠ比值较纤维斑块者高(P<0.01)。载脂蛋白B、Apo B/Apo AⅠ比值对软斑块的诊断均有较好的准确性,ROC曲线下面积分别为0.753±0.067、0.701±0.071。结论载脂蛋白B、Apo B/Apo AⅠ比值及斑块类型与急性心肌梗死密切相关,载脂蛋白B、Apo B/Apo AⅠ比值与以颈动脉超声检测为标准的斑块类型有关。 Aim To investigate the correlation between serum levels of apolipoprotein A I (APOA I ), apoli- poprotein B ( APOB), the ratio of apolipoprotein B to apolipoprotein A I ( ApoB/APOA I ) and carotid plaque type in pa- tients with acute myocardial infarction. Methods This study was carried out on 65 patients with acute myocardial in- farction (case group) and 36 cases whose angiography were normal as control group. Serum APOB and APOA I levels were measured, the ratio of ApoB/APOA I was calculated. All the patients were divided into three groups depending on the components of carotid plaque which was characterized by ultrasound: soft plaque, fibrous plaque and calcified plaque. All the data have been analyzed statistically. Results Soft plaque burden within the case group was significantly high- er than that of the control group (P 〈 0. 001 ). An increased level of APOB and ApoB/ApoA I ratio showed in the case group compared to the control group (P 〈 0.05 ). Compared with fibrous plaque and calcified plaque, serum ApoB levels and ApoB/ApoA I ratio in the case group patients with soft plaque were higher (P 〈 0. 05 ). Compared with fibrous plaque, serum ApoB levels and ApoB/ApoA I ratio in the case group patients with soft plaque were higher ( P 〈 0. 01 ), ApoB and ApoB/APOA I ratio had certain accuracy in the diagnosis of soft plaques and the area under curve (AUC) ofROC were 0. 753 ~ 0. 067 and 0. 701 ~ 0.071 respectively. Conclusions ApoB, ApoB/ApoA I ratio and the type of plaque were markedly associated with acute myocardial infarction. In addition, ApoB and ApoB/ApoA I ratio were relat- ed to the type of plaque which were classified according to the ultrasound.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第12期1236-1240,共5页 Chinese Journal of Arteriosclerosis
关键词 载脂蛋白B 载脂蛋白AⅠ 载脂蛋白B/载脂蛋白AⅠ比值 颈动脉粥样硬化斑块 急性心肌梗死 Apolipoprotein B Apolipoprotein A I Apolipoprotein B/Apolipoprotein A I Ratio CarotidPlaque Acute Myocardial Infarction
  • 相关文献

参考文献6

二级参考文献98

  • 1孙婷,边红放.载脂蛋白B与动脉粥样硬化及冠心病[J].中国误诊学杂志,2005,5(8):1425-1426. 被引量:6
  • 2庄一义.载脂蛋白A1和B的参考值及临床意义[J].中国动脉硬化杂志,2006,14(3):263-266. 被引量:35
  • 3胡良皞,秦永文.载脂蛋白对冠心病的风险预测[J].中国心血管病研究,2007,5(2):147-149. 被引量:5
  • 4KmhtHS, Jones HL, Huang W, et al. Macropinocytesis is the endocytic pathway that mediates macrophage foam cell formation wiht native low density lipoproteni[ J]. J Bid Chem, 2005,280: 2352.
  • 5Walldius G, Jungner I, et al. High apolipopmtein B, low apolipoporotein A-I , and improvement in the prediction of fatal myocardial infarction (AMORIS study) : a prospective study [ J ]. Lancet, 2001,358 ( 9298 ) : 2026.
  • 6Soinio M,Jukka M,Markku L,et al.Elevated plasma homocys-teine level is an independent predictor of coronary heart disease e-vents in patients with type 2 diabetes mellitus[J].Ann Intern Med,2004,140(2):94-100.
  • 7Cushman M,Arnold A,Psaty B,et al.C-reactive protein and the10-year incidence of coronary heart disease in older men andwomen:the cardiol vascular health study[J].Circulation,2005,112(1):25-31.
  • 8Pearson T A,Mensah G A,Alexander R W,et al.Markers of in-flammation and cardiovascular disease:application to clinical andpublic health practice:A statement for healthcare professionals fromthe Centers for Disease Control and Prevention and the AmericanHeart Association[J].Circulation,2003,107(3):499-511.
  • 9Arroyo Espliguero R,Avanzas P,Cosin Sales J,et al.C-reactiveprotein elevation and disease activity in patients with coronary arterydisease[J].Eur Heart J,2004,25(5):401-408.
  • 10Lorenz M W,Karbstein P,Markus H S,et al.High-sensitivity C-reactive protein is not associated with carotid intima-media progres-sion:the carotidatherosclerosis progression study[J].Stroke,2007,38(6):1774-1779.

共引文献41

同被引文献31

  • 1Sinclair H, Bourantas C, Bagnall A, et al. OCT for the identi- fication of vulnerable plaque in acute c()ronary syndrome [J]. JACC Cardiovasc Imaging, 2015, 8 (2) : 198-209.
  • 2Otsuka K, Fukuda S, Tanaka A, et al. Prognosis of vulner- able plaque on computed tomographic coronary angiography with normal myocardial perfusion image [J]. Eur Heart J Cardiovasc Imaging, 2014, 15 (3) : 332-340.
  • 3Salim S, Virani MD, Diane J, et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque char- acteristics : the Atheroscleosis Risk in Communities (ARIC) Carotid MRI Study [J]. Atherosclerosis, 2011, 219 (2): 596-602.
  • 4Takiuchi S, Rakugi H, Honda K, et al. Quantitative ultra- sonic tissue characterization can identify high-risk athero- sclerotic alteration in human carotid arteries [J]. Circulation, 2000, 102 (7): 766-770.
  • 5Liu J, Sempos CT, Donahue RP, et al. Non-high-density lipoprotein and ver-low-density lipoproein cholesterol and their rish predictive values in coronary heart disease [J]. AMJ cardiol, 2005, 98 (10): 1 363-368.
  • 6Di Angelantonio E, Sarwar N, Perry P, et al. Major lip- ids, apolipoproteins, and risk of vascular disease[J]. lA- MA, 2009, 302 (18) : 1 993-2 000.
  • 7Redgrave JNE, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the oxford plaque study [J]. Circulation, 2006, 113 (19) : 2 320-328.
  • 8Wiesner P, Tafelmeier M,Chikkta D,et al.MCP-1 binds to oxidized LDL and is Carried by lipoprotein(a) in human plasma[J].Miller J Lipid Res,2013,54( 7): 1877-1883.
  • 9Klingel R,Heibges A,Fassbender C.Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events:comments on the prospective Pro(a)LiFe study[J].Clin Res Cardiol Suppl,2015,10(1 ):46-50.
  • 10Nordestgaard BG,Chapman MJ,Ray K,et al.Lipoprotein(a) as a cardiovascular risk factor:current status[J].Eur Heart J, 2010,31(23):2844-2853.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部